Wavu Wank

TEKKEN® 8 glicko2 Ratings &
Online Ranked Statistics

Ratings

Rx Meropenem vs Jin 56–70 44.44%
Rx Meropenem vs Kazuya 59–66 47.20%
Rx Meropenem vs King 44–52 45.83%
Rx Meropenem vs Dragunov 31–56 35.63%
Rx Meropenem vs Reina 40–39 50.63%
Rx Meropenem vs Bryan 39–36 52.00%
Rx Meropenem vs Law 32–42 43.24%
Rx Meropenem vs Lili 22–35 38.60%
Rx Meropenem vs Yoshimitsu 30–24 55.56%
Rx Meropenem vs Steve 28–26 51.85%
Rx Meropenem vs Victor 26–27 49.06%
Rx Meropenem vs Hwoarang 20–31 39.22%
Rx Meropenem vs Alisa 23–25 47.92%
Rx Meropenem vs Lars 17–26 39.53%
Rx Meropenem vs Jun 20–20 50.00%
Rx Meropenem vs Paul 14–24 36.84%
Rx Meropenem vs Heihachi 18–20 47.37%
Rx Meropenem vs Devil Jin 14–23 37.84%
Rx Meropenem vs Asuka 16–20 44.44%
Rx Meropenem vs Azucena 20–16 55.56%
Rx Meropenem vs Eddy 18–12 60.00%
Rx Meropenem vs Lee 16–13 55.17%
Rx Meropenem vs Xiaoyu 15–13 53.57%
Rx Meropenem vs Nina 10–14 41.67%
Rx Meropenem vs Leroy 7–15 31.82%
Rx Meropenem vs Clive 11–11 50.00%
Rx Meropenem vs Feng 8–13 38.10%
Rx Meropenem vs Lidia 6–15 28.57%
Rx Meropenem vs Zafina 8–11 42.11%
Rx Meropenem vs Raven 9–8 52.94%
Rx Meropenem vs Claudio 7–6 53.85%
Rx Meropenem vs Leo 5–7 41.67%
Rx Meropenem vs Jack-8 3–8 27.27%
Rx Meropenem vs Kuma 3–1 75.00%
Rx Meropenem vs Shaheen 1–2 33.33%
Rx Meropenem vs Panda 0–3 0.00%
Rx Meropenem vs Anna 2–1 66.67%

Limitations

This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.

For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.

There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.

In the meantime, this page is here to present the data as requested.